INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAA6 Class: NOTE 3.250% 7/0

WOLVERINE ASSET MANAGEMENT LLC's Holding History (CIK: 0001279891)

Note: Option positions (PUT/CALL) are excluded.

Q1 2021
Shares 3,133,000 Value ($000) $2,596 Avg Close — Range —
Q4 2020
Shares 33,083,000 Value ($000) $25,813 Avg Close — Range —
Q3 2020
Shares 70,365,000 Value ($000) $56,390 Avg Close — Range —
Q2 2020
Shares 70,365,000 Value ($000) $52,503 Avg Close — Range —
Q1 2020
Shares 68,865,000 Value ($000) $55,984 Avg Close — Range —
Q4 2019
Shares 50,765,000 Value ($000) $51,442 Avg Close — Range —
Q3 2019
Shares 45,339,000 Value ($000) $39,220 Avg Close — Range —
Q2 2019
Shares 42,636,000 Value ($000) $37,999 Avg Close — Range —
Q1 2019
Shares 17,593,000 Value ($000) $17,494 Avg Close — Range —
Q4 2018
Shares 18,583,000 Value ($000) $17,322 Avg Close — Range —
Q3 2018
Shares 17,948,000 Value ($000) $18,114 Avg Close — Range —
Q3 2017
Shares 10,487,000 Value ($000) $8,138 Avg Close — Range —
Q2 2017
Shares 42,487,000 Value ($000) $41,437 Avg Close — Range —
Q1 2017
Shares 42,307,000 Value ($000) $39,554 Avg Close — Range —
Q4 2016
Shares 42,750,000 Value ($000) $38,435 Avg Close — Range —
Q3 2016
Shares 42,750,000 Value ($000) $47,657 Avg Close — Range —